Table 1.
Characteristics of patients in the DeCi cohort.
| Variable | Patients with decompensated cirrhosis (n = 456) |
|---|---|
| Sex (male), n (%) | 344 (75.4%) |
| Age, median (IQR) | 53.5 (46-63.75) |
| Hospitalization days, median (IQR) | 11 (9-13) |
| Intensive care unit (%) | 64 (14.0%) |
| Cause of liver cirrhosis, n (%) | |
| Viral | 276 (60.5%) |
| Alcoholic | 72 (15.8) |
| Combined alcoholic viral | 37 (8.1%) |
| Other | 28 (6.1%) |
| Cryptogenic | 43 (9.4%) |
| Cause of hospitalization, n (%) | |
| Ascites | 3 (0.7%) |
| Gastrointestinal hemorrhage | 407 (89.2%) |
| Hepatic encephalopathy | 22 (4.8%) |
| Infection | 24 (5.3%) |
| Ascites degree, n (%) | |
| No ascites | 195 (42.8%) |
| 1st-degree ascites | 123 (27.0%) |
| 2nd-degree ascites | 80 (17.5%) |
| 3rd-degree ascites | 58 (12.7%) |
| Renal failure, n (%) | 20 (4.4%) |
| Hepatocellular carcinoma, n (%) | 56 (12.3%) |
| Acute decompensation, n (%) | 436 (95.5%) |
| Therapy, n (%) | |
| Vasopressor support | 144 (31.6%) |
| Mechanical ventilation | 27 (5.9%) |
| Renal replacement therapy | 2 (4.4%) |
| 28-day outcome, n (%) | |
| Lost to follow-up | 31 (6.8%) |
| Survivors | 375 (82.2%) |
| Nonsurvivors | 50 (11.0%) |
| 90-day outcome, n (%) | |
| Lost to follow-up | 77 (16.9%) |
| Survivors | 300 (65.8%) |
| Nonsurvivors | 76 (16.6%) |
| 6-month outcome, n (%) | |
| Lost to follow-up | 132 (28.9%) |
| Survivors | 233 (51.1%) |
| Nonsurvivors | 91 (19.9%) |
IQR: interquartile range.